Bulletin
Investor Alert

London Markets Open in:

Haemonetics Corp.

NYS: HAE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 2, 2023, 4:36 p.m.

HAE
/zigman2/quotes/205816408/composite

$

88.00

Change

-0.13 -0.15%

Volume

Volume 13,806

Quotes are delayed by 20 min

/zigman2/quotes/205816408/composite

Previous close

$ 86.57

$ 88.13

Change

+1.56 +1.80%

Day low

Day high

$86.00

$88.13

Open

52 week low

52 week high

$58.23

$91.39

Open

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/18/2023 Christopher A. Simon
President & CEO; Director
3,839   Derivative/Non-derivative trans. at $83.34 per share. 319,942
05/18/2023 Michelle L. Basil
EVP and General Counsel
3,541   Derivative/Non-derivative trans. at $83.34 per share. 295,106
05/18/2023 Anila Lingamneni
EVP, Chief Technology Officer
1,385   Derivative/Non-derivative trans. at $83.34 per share. 115,425
05/18/2023 Josep Lluis Llorens
EVP, Global Manufacturing
1,423   Derivative/Non-derivative trans. at $83.34 per share. 118,592
05/18/2023 Stewart W. Strong
President, Global Hospital
1,087   Derivative/Non-derivative trans. at $83.34 per share. 90,590
05/18/2023 Laurie A. Miller
SVP, Human Resources
90   Derivative/Non-derivative trans. at $83.34 per share. 7,500
05/02/2023 James C. Darecca
EVP, Chief Financial Officer
430   Derivative/Non-derivative trans. at $81.66 per share. 35,113
04/14/2023 Anila Lingamneni
EVP, Chief Technology Officer
176   Derivative/Non-derivative trans. at $84.78 per share. 14,921
01/23/2023 Josep Lluis Llorens
EVP, Global Manufacturing
2,391   Disposition at $90 per share. 215,190
01/23/2023 Josep Lluis Llorens
EVP, Global Manufacturing
2,391   Derivative/Non-derivative trans. at $56.57 per share. 135,258
11/11/2022 Christopher A. Simon
President & CEO; Director
8,600   Gift at $0 per share. 0
11/01/2022 Roy Galvin
President, Global Plasma & BC
2,382   Award at $0 per share. 0
10/24/2022 Michelle L. Basil
EVP and General Counsel
180   Disposition at $80.39 per share. 14,470
10/24/2022 Stewart W. Strong
President, Global Hospital
75   Disposition at $80.39 per share. 6,029
09/19/2022 Michelle L. Basil
EVP and General Counsel
11,448   Disposition at $78.36 per share. 897,065
09/19/2022 Laurie A. Miller
SVP, Human Resources
212   Disposition at $76.25 per share. 16,165
09/19/2022 Michelle L. Basil
EVP and General Counsel
1,011   Derivative/Non-derivative trans. at $56.57 per share. 57,192
09/19/2022 Michelle L. Basil
EVP and General Counsel
4,213   Derivative/Non-derivative trans. at $41.64 per share. 175,429
09/19/2022 Michelle L. Basil
EVP and General Counsel
3,464   Derivative/Non-derivative trans. at $38.43 per share. 133,121
09/15/2022 Michelle L. Basil
EVP and General Counsel
6,029   Disposition at $78.5 per share. 473,276
09/15/2022 Michelle L. Basil
EVP and General Counsel
27,769   Disposition at $77.76 per share. 2,159,317
09/15/2022 Michelle L. Basil
EVP and General Counsel
3,173   Derivative/Non-derivative trans. at $56.57 per share. 179,496
09/15/2022 Michelle L. Basil
EVP and General Counsel
14,231   Derivative/Non-derivative trans. at $41.64 per share. 592,578
09/15/2022 Michelle L. Basil
EVP and General Counsel
11,154   Derivative/Non-derivative trans. at $38.43 per share. 428,648
09/06/2022 Josep Lluis Llorens
EVP, Global Manufacturing
101   Disposition at $73.78 per share. 7,451
/news/latest/company/us/hae

MarketWatch News on HAE

  1. Haemonetics started at buy with $90 stock price target at Mizuho

    6:39 a.m. Oct. 13, 2022

    - Tomi Kilgore

  2. Futures Rise Ahead of July Inflation Data

    7:54 p.m. Aug. 9, 2022

    - Barron's Online

  3. Haemonetics downgraded to hold from buy at Needham

    6:57 a.m. Jan. 27, 2022

    - Tomi Kilgore

  4. 10 Hidden Gems in the Rush for Covid-Vaccine Stocks

    1:51 p.m. Nov. 10, 2020

    - Barron's Online

  5. How a Small-Cap Fund Weeds Out the Worst Stocks

    9:30 p.m. Sept. 6, 2019

    - Barron's Online

  6. Haemonetics upgraded to outperform from market perform at Raymond James

    8:16 a.m. May 14, 2019

    - Tomi Kilgore

  7. The best and worst stocks of 2018

    10:27 a.m. Jan. 3, 2019

    - Philip van Doorn

  8. Haemonetics downgraded to neutral from buy at Sidoti & Co.

    2:55 p.m. Aug. 15, 2016

    - Tomi Kilgore

  9. Haemonetics upgraded to neutral from sell at Goldman Sachs

    1:59 p.m. May 16, 2016

    - Tomi Kilgore

  10. Bad Omen? Losers Lead Way in Market Bounce

    8:22 a.m. Feb. 2, 2016

    - Barron's Online

  11. Morning Movers: PepsiCo Jumps on Earnings Beat; Tesla Slips

    8:28 a.m. Oct. 6, 2015

    - Barrons Blogs

  12. Haemonetics shares fall after outlook cut

    5:16 p.m. Oct. 5, 2015

    - Wallace Witkowski

  13. Preview

    11:25 p.m. May 15, 2015

    - Barron's Online

  14. Research Reports

    3:34 a.m. Jan. 4, 2014

    - Barron's Online

  15. Preview

    3:08 p.m. May 13, 2013

    - Barron's Online

  16. Health-care stocks insiders are betting on

    12:02 p.m. Jan. 30, 2013

    - Insider Monkey

  17. Bulls, bears make case while surfing fiscal cliff

    2:37 p.m. Dec. 4, 2012

    - Michael Ashbaugh

  18. Loading more headlines...
/news/nonmarketwatch/company/us/hae

Other News on HAE

  1. 10-Q: HAEMONETICS CORP

    7:20 a.m. Feb. 7, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Aurora Investment Counsel Buys 3, Sells 2 in 4th Quarter

    7:00 p.m. Feb. 3, 2023

    - GuruFocus.com

  3. Top 5 4th Quarter Trades of LGT CAPITAL PARTNERS LTD.

    3:00 p.m. Jan. 19, 2023

    - GuruFocus.com

  4. Haemonetics (HAE) Q2 Earnings Beat Estimates, 2023 View Up

    10:49 a.m. Nov. 11, 2022

    - Zacks.com

  5. 10-Q: HAEMONETICS CORP

    6:05 p.m. Nov. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. Company News for Nov 8, 2022

    10:26 a.m. Nov. 8, 2022

    - Zacks.com

  7. Haemonetics Corporation (HAE) Q2 2023 Earnings Call Transcript

    12:17 p.m. Nov. 7, 2022

    - Seeking Alpha

  8. Centene (CNC) to Post Q3 Earnings: What's in the Cards?

    12:06 p.m. Oct. 20, 2022

    - Zacks.com

  9. Haemonetics (HAE) Hospital Arm Aids, Macro Issues Persist

    11:40 a.m. Sept. 30, 2022

    - Zacks.com

  10. Here's Why Haemonetics (HAE) is a Strong Growth Stock

    9:45 a.m. Sept. 30, 2022

    - Zacks.com

  11. Haemonetics (HAE) to Offer Two VASCADE Devices in the EU

    1:41 p.m. Sept. 14, 2022

    - Zacks.com

Link to MarketWatch's Slice.